HQ
Oxford, UK
FOUNDED
2019
AFFILIATIONS & QUALIFICATIONS
Entrepreneur First, University of Oxford
Mining the immune system for therapeutic T cells to tackle cancer and immune aging
THE IDEA
Exogene is a biotechnology company developing T-cell-receptor(TCR)-based cell therapies to tackle solid tumours and immune aging
THE TECHNOLOGY
Exogene's technology combines artificial intelligence, high-throughput TCR screening and deep sequencing to mine the immune system for rare, natural TCRs against novel targets. Exogene then uses these TCRs to develop its own pipeline of TCR-based cell therapies